This company has been marked as potentially delisted and may not be actively trading. OTCMKTS:ALXA ALXA (ALXA) Stock Price, News & Analysis Add Share Share Stock Analysis Stock AnalysisBuy This Stock About ALXA Stock (OTCMKTS:ALXA) 30 days 90 days 365 days Advanced Chart Get ALXA alerts:Sign Up Key Stats Today's Range$0.94▼$0.9450-Day Range N/A52-Week Range$0.22▼$1.60Volume100 shsAverage Volume158,340 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewAlexza Pharmaceuticals, Inc. is a pharmaceutical company focused on the research, development and commercialization of products for the acute treatment of central nervous system conditions. The Company's product candidates are based on the Staccato system technology. Its product candidates in development include AZ-002, which contains alprazolam as an active pharmaceutical ingredient (API) is developed for the management of patients with acute repetitive seizures, and AZ-007, which contains zaleplon as API is developed for the treatment of insomnia in patients who have difficulty falling asleep, including those patients with middle of the night awakening having difficulty falling back asleep. Its product also includes ADASUVE, which contains loxapine as API is developed for the treatment of agitation associated with schizophrenia or bipolar disorder. It has initiated a Phase IIa proof-of-concept study for AZ-002 in patients with epilepsy and has completed Phase I testing for AZ-007.Read More… Receive ALXA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ALXA and its competitors with MarketBeat's FREE daily newsletter. Email Address ALXA Stock News HeadlinesAlexa, Find Me a Deal—This Echo Pop Just Dropped 30%May 5 at 12:29 PM | msn.comTo celebrate May the 4th, ask Alexa these Star Wars questionsMay 3 at 3:46 AM | msn.comAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.May 6, 2025 | Paradigm Press (Ad)Amazon CEO says 100,000 users now have Alexa+May 3 at 3:46 AM | techcrunch.comSusan Solves It: Alexa Privacy ConcernsApril 29, 2025 | yahoo.comUltimate Alexa Guide: 200+ Commands to Master Amazon Echo and New Alexa PlusApril 29, 2025 | cnet.comAlexa Easter Eggs: All the Meme-tastic Things You Should Ask Your Amazon Echo Right NowApril 28, 2025 | msn.comAlexa, Hear me out!April 27, 2025 | msn.comSee More Headlines ALXA Stock Analysis - Frequently Asked Questions How were ALXA's earnings last quarter? ALXA (OTCMKTS:ALXA) released its earnings results on Wednesday, May, 11th. The healthcare company reported ($0.16) earnings per share for the quarter. The healthcare company had revenue of $0.72 million for the quarter. What other stocks do shareholders of ALXA own? Based on aggregate information from My MarketBeat watchlists, some other companies that ALXA investors own include Anavex Life Sciences (AVXL), Pernix Therapeutics (PTX), BioDelivery Sciences International (BDSI), PayPal (PYPL), Achillion Pharmaceuticals (ACHN), Bank of America (BAC) and Bristol-Myers Squibb (BMY). Company Calendar Last Earnings5/11/2016Today5/06/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorN/A Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:ALXA Previous SymbolNASDAQ:ALXA CIK1344413 Webwww.alexza.com Phone+1-650-9447000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:ALXA) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Being Erased – Save It Before It’s Gone ForeverWhat If America's Gold Reserves Are a Lie? For decades, the U.S. government has claimed to have thousands o...Hamilton Gold Group | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALXA Please log in to your account or sign up in order to add this asset to your watchlist. Share ALXA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.